Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study

por Sánchez, Manuel Anguita, Marín, Francisco, Masjuan, Jaime, Cosín-Sales, Juan, Rodríguez, José Manuel Vázquez, Barrios, Vivencio, Barón-Esquivias, Gonzalo, Lekuona, Iñaki, Pérez-Cabeza, Alejandro I., Freixa-Pamias, Román, Jimenez, Francisco Javier Parra, Khatib, Mohamed Monzer Khanji, Priu, Carles Rafols, Fernández, Marcelo Sanmartín
Publicado 2022